Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

VCY Inhibitors

Variable Charge Y-Linked (VCY) proteins are a unique set of proteins encoded by genes present on the Y chromosome. Expressed predominantly in the testis, they have garnered interest for their potential involvement in spermatogenesis, though the full extent of their biological roles and interactions is not entirely elucidated. As researchers delve deeper into the intricate networks of cellular processes, understanding the modulation of such proteins becomes paramount. Enter VCY inhibitors: a class of chemical entities specifically designed or identified to dampen or suppress the expression or function of VCY proteins.

The world of VCY inhibitors is expansive. These chemical compounds act at various stages of the VCY protein lifecycle. Some might interfere at the genetic level, targeting the transcriptional machinery responsible for converting the VCY gene into mRNA. Others target the translational mechanisms, ensuring that the mRNA does not successfully translate into the functional VCY protein. Another subset may act post-translationally, altering the stability or function of the VCY proteins after they have been synthesized. Additionally, epigenetic modulators could also play a role; these inhibitors might alter the chromatin landscape around the VCY gene, making it less accessible to the cellular machinery and thereby reducing its expression. The diversity in the modes of action offers researchers a broad spectrum of tools to dissect the importance and function of VCY in cellular biology. As the scientific community advances in its understanding, the exploration of these inhibitors will be pivotal in revealing the nuances of Y-chromosome associated proteins and their contributions to cellular dynamics.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D may bind to DNA regions associated with the VCY gene, possibly obstructing its transcription.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

This compound could selectively hinder the translation of VCY mRNA, potentially reducing its protein production.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By modifying the methylation patterns of genes, 5-Azacytidine might affect the transcription of the VCY gene.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

By inhibiting histone deacetylase, Trichostatin A might influence chromatin structure around the VCY gene, potentially suppressing its expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

This compound could inhibit RNA polymerase II, leading to a decrease in VCY mRNA transcription.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin could affect DNA topoisomerase I function, possibly impacting replication and transcription of the VCY gene.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

By inhibiting glycolysis, 2-Deoxyglucose might reduce cellular energy essential for VCY synthesis.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB could obstruct RNA polymerase II, potentially leading to a decrease in VCY mRNA synthesis.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

By affecting ribonucleotide reductase, hydroxyurea could impact DNA synthesis and the transcription of the VCY gene.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin might bind to Hsp90, possibly leading to destabilization or degradation of proteins requiring Hsp90 for proper folding, including potentially VCY.